TI
KRYS icon

Trexquant Investment’s Krystal Biotech KRYS Stock Holding History

Trexquant Investment’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,122
Closed -$2.37M – 1725
2025
Q1 		$2.37M Buy
+13,122
New +$2.21M 0.03% 806
2024
Q2 		– Sell
-13,293
Closed -$2.37M – 1700
2024
Q1 		$2.37M Buy
+13,293
New +$1.85M 0.05% 583
2023
Q4 		– Sell
-8,113
Closed -$941K – 1630
2023
Q3 		$941K Buy
8,113
+657
+9% +$80.2K 0.02% 778
2023
Q2 		$875K Buy
+7,456
New +$761K 0.02% 804

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Trexquant Investment's KRYS Position: Q2 2025 in Review

Trexquant Investment sold out of Krystal Biotech (KRYS) in Q2 2025, closing a stake of 13,122 shares — an estimated $2.37M sold.

Trexquant Investment first reported a position in KRYS in Q2 2023 and held it in 4 quarters. The position peaked at $2.37M in Q1 2025. 275 funds tracked by Wall St. Rank hold KRYS as of Q2 2025.

  • Trexquant Investment reported no remaining Krystal Biotech position as of Q2 2025 after selling out during the quarter.
  • Trexquant Investment sold 13,122 Krystal Biotech shares in Q2 2025, an estimated $2.37M.
  • Trexquant Investment first reported a position in Krystal Biotech in Q2 2023 and held it in 4 quarters.
  • Trexquant Investment's Krystal Biotech position peaked at $2.37M in Q1 2025.
  • 275 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2025.

Based on Trexquant Investment's 13F filing for Q2 2025, filed 12 Aug 2025.